ROW Territory Sample Clauses
The "ROW Territory" clause defines the geographic scope of rights or obligations as covering the "Rest of World"—that is, all countries or regions not specifically named elsewhere in the agreement. In practice, this clause is used to clarify that certain terms, such as licensing, distribution, or sales rights, apply globally except for territories that are explicitly excluded or separately addressed. Its core function is to prevent ambiguity about where contractual rights or restrictions apply, ensuring comprehensive coverage and reducing the risk of disputes over territorial scope.
POPULAR SAMPLE Copied 1 times
ROW Territory. Pfizer shall indemnify, defend and hold Eyetech Parties harmless from and against [**] percent ([**]%) of the amount of any and all Losses arising out of or resulting from any Third Party Claim involving Product Liability in the ROW Territory (other than Product Liability Losses for which Eyetech is obligated to indemnify Pfizer pursuant to Section 12.4).
ROW Territory. Celgene shall have lead responsibility for all Regulatory Interactions with Regulatory Authorities in the ROW Territory for each Shared Product.
ROW Territory. Alkermes shall share with Cephalon relevant materials, data and regulatory information in Alkermes' or its Affiliates' possession and Control related to any pre-clinical studies, Clinical Studies and post marketing clinical trials of a Product in the Field resulting from its collaborations with respect to the Product for the ROW Territory to the extent such materials, data or regulatory information are necessary or useful for filing an IND or NDA or required to be disclosed by Law. In return Cephalon agrees that Alkermes may share with its collaborators with respect to the Product in the ROW Territory, subject to the provisions of Article 8, [**].
ROW Territory. Pfizer shall indemnify, defend and hold the Eyetech Parties harmless from and against [**] percent ([**]%) of the amount of any and all Losses arising out of or resulting from any Third Party Claims involving any actual or alleged infringement of any trademarks, patent rights or other intellectual property rights, or misappropriation of trade secrets, of any Person in connection with the manufacture, use, sale or importation of the Product in the ROW Territory or in connection with the manufacture or use of the Product in the US Territory for subsequent importation and/or sale in the ROW Territory (other than Losses for which Eyetech is obligated to indemnify Pfizer pursuant to Section 12.4 and other than Losses relating to Products ultimately sold by Eyetech in the US Territory, which are governed by Section 12.6(b)(i)).
ROW Territory. The term “
ROW Territory. Alkermes retains all of its rights to use, sell, manufacture, offer for sale and import the Products in the ROW Territory. During the period beginning on the Effective Date and ending one hundred eighty (180) days thereafter (the "Option Period"), Alkermes shall not enter into any agreement or negotiation with any Third Party regarding a license of the rights to use, sell, offer for sale and import the Products in the ROW Territory. If during the Option Period Cephalon notifies Alkermes in writing of its desire to enter into an exclusive license to use, sell, offer for sale and import the Products in the ROW Territory, then Alkermes shall exclusively negotiate with Cephalon in good faith a definitive agreement for such an exclusive license containing customary representations, warranties, covenants and agreements, satisfactory in form and substance to the Parties and their legal advisors, as are necessary or appropriate for transactions of this type. If Cephalon does not notify Alkermes of its desire to enter into such an exclusive license within the Option Period, or if at the end of the Option Period Alkermes and Cephalon are unable to agree on terms for such a definitive license, then Alkermes shall be free to use, sell, manufacture, offer for sale and import the Products in the ROW Territory itself or to initiate discussions and execute a license with one or more Third Parties to do so, with no further obligation to Cephalon under this Agreement. [**].
ROW Territory. Neutron ROW shall pay Seller the following percentages of its Net Sales in the ROW Territory (the “ROW Royalty Payments”):
(A) Fifteen percent (15%) for Net Sales in the ROW Territory below One Hundred Million Dollars ($100,000,000.00);
(B) Seventeen and one half percent (17.5%) for Net Sales in the ROW Territory from One Hundred Million Dollars ($100,000,000.00) to Two Hundred and Fifty Million Dollars ($250,000,000.00); and
(C) Twenty percent (20%) for Net Sales in the ROW Territory above Two Hundred and Fifty Million Dollars ($250,000,000.00).
(D) The ROW Royalty Payments shall be payable on a quarterly basis and each such payment shall be made in arrears by Neutron ROW to Seller within forty-five (45) days following the applicable fiscal quarter end of Neutron ROW. Notwithstanding the foregoing Section 7.2(a)(ii), if Neutron ROW is required to pay any Third Party Technology Payment in respect of its Net Sales in the ROW Territory, any ROW Royalty Payment associated with such Net Sales shall be, without duplication, reduced by twenty-two percent (22%) of such Third Party Technology Payment.
ROW Territory. Chroma, its Affiliates and sublicensees shall comply with all applicable Laws and guidelines in the ROW Territory applicable to the Commercialization of pharmaceutical products.
ROW Territory. 38 6.7 Termination of License to Contested Patent Rights............... 39
ROW Territory. Takeda, its Affiliates and sublicencees shall comply with all applicable Laws and guidelines in the ROW Territory applicable to the marketing, sale and promotion of pharmaceutical products.